Form 8-K - Current report:
SEC Accession No. 0001628280-16-015095
Filing Date
2016-04-29
Accepted
2016-04-29 17:23:18
Documents
1
Period of Report
2016-04-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K - APRIL 2016 VOTE OF SHAREHOLDERS a8k-april2016xvoteofannual.htm 8-K 37666
  Complete submission text file 0001628280-16-015095.txt   38709
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 161608484
SIC: 2834 Pharmaceutical Preparations